NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDObinutuzumab Gazyvaro ® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Obinutuzumab Obinutuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA343: Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
NICE TA472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab
NICE TA513: Obinutuzumab for untreated advanced follicular lymphoma
NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab
NICE TA663: Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
NICE TA978: Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (TERMINATED APPRAISAL)